1-7 of 7
Jong-In Park
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1099: Combined MEK and RET inhibition overcomes resistance to single agent RET inhibition in medullary thyroid cancer

Arwa Fallatah, Abdelrahman Rahmy, Sophia Khan, Hsien-chao Chou, Kerstin Heselmeyer-Haddad, Darawalee Wangsa, David Milewski, Yong Kim, Robert Hawley, Young Song, Xiaohu Zhang, Craig Thomas, Jun S. Wei, Jong-In Park, John Glod, Javed Khan
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 1099.
https://doi.org/10.1158/1538-7445.AM2024-1099
Published: 22 March 2024
View article titled, Abstract 1099: Combined MEK and RET inhibition overcomes resistance to single agent RET inhibition in medullary thyroid cancer
Journal Articles

Abstract 1528: Cooperative cross-talk between neuroblastoma subtypes confers resistance to anaplastic lymphoma kinase inhibition

Andrew M. Chan, Xiaocai Yan, Colin R. Kennedy, Sarah B. Tilkens, Olena Wiedemeier, Hong Guan, Jong-In Park
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1528.
https://doi.org/10.1158/1538-7445.AM2012-1528
Published: 15 April 2012
View article titled, Abstract 1528: Cooperative cross-talk between neuroblastoma subtypes confers resistance to anaplastic lymphoma kinase inhibition
Journal Articles

Abstract 2616: The immunoproteasome subunit LMP2 as a novel therapeutic target for non-small cell lung cancer

Marie Wehenkel, Eun Ryoung Jang, Kimberly Cornish, Kyunghwa Kim, Jee Eun Kim, Eun Y. Lee, Wooin Lee, Jong-In Park, Kyung Bo Kim
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 2616.
https://doi.org/10.1158/1538-7445.AM2011-2616
Published: 15 April 2011
View article titled, Abstract 2616: The immunoproteasome subunit LMP2 as a novel therapeutic target for non-small cell lung cancer
Journal Articles

Abstract #4391: The Raf/MEK/ERK pathway can mediate androgen receptor downregulation and growth arrest independently of ERK1/2 kinase activity in LNCaP cells

Seung-Keun Hong, Seunghee Yoon, Jong-In Park
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 4391.
Published: 01 May 2009
View article titled, Abstract #4391: The Raf/MEK/ERK pathway can mediate androgen receptor downregulation and growth arrest independently of ERK1/2 kinase activity in LNCaP cells
Journal Articles

Cyclin-Dependent Kinase 5 Activity Controls Cell Motility and Metastatic Potential of Prostate Cancer Cells

Christopher J. Strock, Jong-In Park, Eric K. Nakakura, G. Steven Bova, John T. Isaacs, Douglas W. Ball, Barry D. Nelkin
Journal: Cancer Research
Cancer Res (2006) 66 (15): 7509–7515.
https://doi.org/10.1158/0008-5472.CAN-05-3048
Published: 02 August 2006
View article titled, Cyclin-Dependent Kinase 5 Activity Controls Cell Motility and Metastatic Potential of Prostate Cancer Cells
Open the PDF for Cyclin-Dependent Kinase 5 Activity Controls Cell Motility and Metastatic Potential of Prostate Cancer Cells in another window
Includes: Multimedia, Supplementary data
Journal Articles

CEP-701 and CEP-751 Inhibit Constitutively Activated RET Tyrosine Kinase Activity and Block Medullary Thyroid Carcinoma Cell Growth

Christopher J. Strock, Jong-In Park, Mark Rosen, Craig Dionne, Bruce Ruggeri, Susan Jones-Bolin, Samuel R. Denmeade, Douglas W. Ball, Barry D. Nelkin
Journal: Cancer Research
Cancer Res (2003) 63 (17): 5559–5563.
Published: 18 September 2003
View article titled, CEP-701 and CEP-751 Inhibit Constitutively Activated RET Tyrosine Kinase Activity and Block Medullary Thyroid Carcinoma Cell Growth
Open the PDF for CEP-701 and CEP-751 Inhibit Constitutively Activated RET Tyrosine Kinase Activity and Block Medullary Thyroid Carcinoma Cell Growth in another window
Journal Articles

Epidermal Growth Factor Receptor-independent Constitutive Activation of STAT3 in Head and Neck Squamous Cell Carcinoma Is Mediated by the Autocrine/Paracrine Stimulation of the Interleukin 6/gp130 Cytokine System

Virote Sriuranpong, Jong In Park, Panomwat Amornphimoltham, Vyomesh Patel, Barry D. Nelkin, J. Silvio Gutkind
Journal: Cancer Research
Cancer Res (2003) 63 (11): 2948–2956.
Published: 01 June 2003
View article titled, Epidermal Growth Factor Receptor-independent Constitutive Activation of STAT3 in Head and Neck Squamous Cell Carcinoma Is Mediated by the Autocrine/Paracrine Stimulation of the Interleukin 6/gp130 Cytokine System
Open the PDF for Epidermal Growth Factor Receptor-independent Constitutive Activation of STAT3 in Head and Neck Squamous Cell Carcinoma Is Mediated by the Autocrine/Paracrine Stimulation of the Interleukin 6/gp130 Cytokine System in another window